These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29659307)

  • 41. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and application of ultrasound contrast agents in biomedicine.
    Wang Y; Cong H; Wang S; Yu B; Shen Y
    J Mater Chem B; 2021 Sep; 9(37):7633-7661. PubMed ID: 34586124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of Contrast Agent Microbubbles for Ultrasound Imaging and Therapy Research.
    Mulvana H; Browning RJ; Luan Y; de Jong N; Tang MX; Eckersley RJ; Stride E
    IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):232-251. PubMed ID: 27810805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities.
    Curley CT; Sheybani ND; Bullock TN; Price RJ
    Theranostics; 2017; 7(15):3608-3623. PubMed ID: 29109764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasound-based multimodal molecular imaging and functional ultrasound contrast agents.
    Lin Y; Chen ZY; Yang F
    Curr Pharm Des; 2013; 19(18):3342-51. PubMed ID: 23448498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound bio-effects and safety considerations.
    ter Haar G
    Front Neurol Neurosci; 2015; 36():23-30. PubMed ID: 25531660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.
    Klibanov AL
    Invest Radiol; 2006 Mar; 41(3):354-62. PubMed ID: 16481920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. State-of-the-art of microbubble-assisted blood-brain barrier disruption.
    Song KH; Harvey BK; Borden MA
    Theranostics; 2018; 8(16):4393-4408. PubMed ID: 30214628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasound-mediated targeted drug delivery: recent success and remaining challenges.
    Castle J; Butts M; Healey A; Kent K; Marino M; Feinstein SB
    Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H350-7. PubMed ID: 23203969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles?
    Wilson SR; Greenbaum LD; Goldberg BB
    AJR Am J Roentgenol; 2009 Jul; 193(1):55-60. PubMed ID: 19542395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Future developments in neurovascular ultrasound.
    Meairs S; Hennerici MG
    Front Neurol Neurosci; 2006; 21():261-268. PubMed ID: 17290144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery.
    Appelboom G; Detappe A; LoPresti M; Kunjachan S; Mitrasinovic S; Goldman S; Chang SD; Tillement O
    Neuro Oncol; 2016 Dec; 18(12):1601-1609. PubMed ID: 27407134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High intensity focused ultrasound for the treatment of tumors.
    ter Haar GR
    Echocardiography; 2001 May; 18(4):317-22. PubMed ID: 11415504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic and therapeutic research on ultrasound microbubble/nanobubble contrast agents (Review).
    Ma J; Xu CS; Gao F; Chen M; Li F; Du LF
    Mol Med Rep; 2015 Sep; 12(3):4022-4028. PubMed ID: 26081968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
    Zhao YZ; Lu CT; Li XK; Cai J
    Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening.
    Jones RM; Deng L; Leung K; McMahon D; O'Reilly MA; Hynynen K
    Theranostics; 2018; 8(11):2909-2926. PubMed ID: 29896293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in mechanism studies on ultrasonic gene delivery at cellular level.
    Yu J; Chen Z; Yan F
    Prog Biophys Mol Biol; 2019 Mar; 142():1-9. PubMed ID: 30031881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
    Gray MD; Lyon PC; Mannaris C; Folkes LK; Stratford M; Campo L; Chung DYF; Scott S; Anderson M; Goldin R; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
    Radiology; 2019 Apr; 291(1):232-238. PubMed ID: 30644817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nano-sized Ultrasound Contrast Agents for Cancer Therapy and Theranostics.
    Li H; Gan S; Feng ST; Zhou G; Dong Z; Zheng R; Li ZP
    Curr Pharm Des; 2017; 23(35):5403-5412. PubMed ID: 28699518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.